Protech Pharmaservices Corporation (PPC) was founded in Taipei in 1997, to meet the growing demands for R&D outsourcing in Taiwan.  Since then, we have developed an excellent reputation in the Asia-Pacific region as a CRO which provides integrated, customized, state-of-the-art clinical research management services to the pharmaceutical, biotechnology and medical device industries.

We established Taiwan’s first Central Laboratory for new drug development, which has been validated for industry standards compliance by US-based professional organizations, the College of American Pathologists (CAP).  Our Bioanalytical Laboratory has also received accreditation from China’s comprehensive laboratory accreditation program, Chinese National Laboratory Accreditation (CNLA).  In combination with PPC's 50-bed Pharmacokinetic Study Unit, we offer a safe, well-controlled and state-of-the-art environment for drug development and sample processing.

At PPC, we insist on delivering the highest levels of excellence, skills and professionalism, to ensure that all of our clients benefit from the highest quality and timely, cost-effective services.